Compounded Hair and Scalp Formulations
Formulary reviewed by Benn Bluestein-Veyra, M.Sc. Organic Chemistry · Founder, ExaVeyra Sciences
Four scalp solutions, prepared against a prescription for an individual patient. Selection, suitability and counseling are prescriber matters; this page covers what the pharmacy can prepare and how it is dated.
The defining procurement fact in this category is that its beyond-use dating is not uniform. Three of the four entries are dated far shorter than the fourth, and the per-fill ceilings move with them.
Supply and documentation
- Lead time
- 3 to 5 business days from order to delivery, covering both preparation and transit.
- Coverage
- licensed in 33+ states, with licensure confirmed for your destination before a first order ships
- Testing
- Endotoxin and sterility testing on every sterile batch
- Every formulary page is checked by a chemist. ExaVeyra was founded by an M.Sc. organic chemist, and specification data is verified against the source catalog rather than reproduced from a vendor sheet.
- One verified account covers biologics, 503A compounded formulations and devices, with a single account manager rather than a separate vendor relationship for each.
Available Formulations
4 preparations with 4 strength and format options, as topical solutions. Beyond-use dates on the label: 35 to 180 days.
What the pharmacy can prepare. This is not a dosing recommendation, and it does not indicate suitability for any patient. Beyond-use dates are assigned at compounding and printed on each label; the shortest applicable limit governs.
GHK-Cu 1%
Scalp Solution
| Strength & size | Beyond-use date | Quantity per fill |
|---|---|---|
| Solution 30 mL | 35 days | Max 1 unit |
Minoxidil 5% / Finasteride 0.1%
Solution
| Strength & size | Beyond-use date | Quantity per fill |
|---|---|---|
| 60 mL | 35 days | Max 1 unit |
Minoxidil 5% / Tretinoin 0.025%
Solution
| Strength & size | Beyond-use date | Quantity per fill |
|---|---|---|
| 60 mL | 180 days | Up to 5 units |
Minoxidil 5% / Azelaic Acid 12.5% / Finasteride 0.1% / Ketoconazole 2%
Solution
| Strength & size | Beyond-use date | Quantity per fill |
|---|---|---|
| 60 mL | 35 days | Max 1 unit |
The dating split is the thing to plan around
Most categories in this catalog share one dating profile. This one does not. Three entries carry a short beyond-use date with a single-unit ceiling per fill, while one solution carries the long date and a five-unit ceiling.
That asymmetry is worth planning around. The short-dated entries move on their own clock, so they reorder on their own line rather than alongside the long-dated solution. Setting that up once keeps every unit arriving with useful life ahead of it.
Read the table per row
The beyond-use date and the per-fill ceiling are stated for each entry separately in this category, and they differ. Each row carries its own, so read them per entry.
Finasteride appears only as a topical component
Finasteride is present in this category only as a component, at a fraction of a percent, in two of the scalp solutions. Oral finasteride tablets are commercially available as a finished product and are not compounded, so they are not part of this formulary.
The prescriber determines which solution is appropriate for a given patient, and the pharmacy prepares what the prescription specifies.
What the solutions contain
- A minoxidil and finasteride combination at 5 percent and 0.1 percent, in 60 mL.
- A minoxidil and tretinoin combination at 5 percent and 0.025 percent, in 60 mL.
- A four-active combination adding azelaic acid at 12.5 percent and ketoconazole at 2 percent to the minoxidil and finasteride base, in 60 mL.
- A copper tripeptide solution at 1 percent, in 30 mL, which is the only entry here not built on minoxidil.
Percentages are fixed per formulation and are not selectable at order time. The four-active solution is the most complex preparation in the catalog by component count, which is reflected in both its dating and its per-fill ceiling.
Container formats and storage
The minoxidil combinations are supplied in 60 mL, the copper tripeptide solution in 30 mL, and the tablet by count. Store as stated on the container label. None of these are cold chain. Keep them in the supplied container so the lot record and the dating on the label stay intact.
The prescribing information for oral finasteride states that it is not indicated for use in women, and sets out the warnings and adverse reactions a prescriber is expected to review before prescribing. [1]
FDA notes that compounded drugs are not reviewed by the agency for safety, quality or labeling before they reach patients, which is why the prescriber and the pharmacy carry that responsibility between them. [2]
Sources
- DailyMed, FINASTERIDE tablet prescribing information (accessed 2026-08-09)
- FDA, Understanding the Risks of Compounded Drugs (accessed 2026-08-09)
Request the full formulary and pricing
The pages on this site list a representative selection. Verified practitioners receive the complete named formulary, current pricing, available strengths and formats, and the identity and credentials of the compounding pharmacy that prepares each preparation.
Access requires a valid NPI. Compounded formulations are prepared by our 503A pharmacy partner, a compounding pharmacy licensed by the Texas State Board of Pharmacy. We verify the number against the national registry, and our team reviews each practice before releasing the formulary, which is why pricing is not published openly: these are prescription preparations supplied to licensed practices rather than consumer products.
Already verified? Sign in to the provider portal
Compounded medications are not FDA-approved finished drug products. Preparations are dispensed against a prescription for a named patient. Nothing on this page is medical advice or a recommendation for any patient.
Frequently asked questions
- Why do some entries here allow only one unit per fill?
- The per-fill ceiling tracks the beyond-use date, so every unit arrives with useful life ahead of it. The figure for each entry is in the table.
- Can the four-active solution be prepared without one component?
- Modified formulations are assessed case by case. Send the change you need to your account manager and the pharmacy will confirm whether it can compound and document it.
- Is the copper tripeptide solution interchangeable with the cosmeceutical creams?
- They are different preparations: a different concentration, a different vehicle and a different container size. The cosmeceutical topicals are a separate category with their own table.
- How should reorders be scheduled?
- The beyond-use date is specific to each formulation, so reorders are calculated from the program the clinician determines is appropriate for the compound and the patient. A clinician can schedule reorders as each individual case requires, within maximum fill periods that vary by formulation. Request the full formulary for the details of each preparation.
- What documentation ships with an order?
- Lot identification on the container label, with a Certificate of Analysis available on request. Practices with their own documentation requirements should raise them at account setup so the pharmacy can confirm what it is able to supply.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Compounded medications are not FDA-approved and are prepared by a licensed 503A compounding pharmacy per individual patient prescription. Formulations are supplied to NPI-verified licensed practitioners only. A Certificate of Analysis and lot documentation are available on request. Nothing on this page is medical advice, a dosing recommendation, or a statement that any formulation is suitable for a given patient. Selection of any formulation in this category, including counseling on the labeling that applies to its components, is the responsibility of the prescribing practitioner.
Reviewed 2026-08-09 by Benn Bluestein-Veyra, M.Sc. Organic Chemistry, founder, exaveyra sciences. Specifications on this page are transcribed from the pharmacy formulary and checked line by line against the source catalog.